SANES

9.247

-0.1%↓

BBVA

18.59

+0.27%↑

ALV

371.5

+0.05%↑

MUV2

543.6

-0.11%↓

INGA

22.345

-0.62%↓

SANES

9.247

-0.1%↓

BBVA

18.59

+0.27%↑

ALV

371.5

+0.05%↑

MUV2

543.6

-0.11%↓

INGA

22.345

-0.62%↓

SANES

9.247

-0.1%↓

BBVA

18.59

+0.27%↑

ALV

371.5

+0.05%↑

MUV2

543.6

-0.11%↓

INGA

22.345

-0.62%↓

SANES

9.247

-0.1%↓

BBVA

18.59

+0.27%↑

ALV

371.5

+0.05%↑

MUV2

543.6

-0.11%↓

INGA

22.345

-0.62%↓

SANES

9.247

-0.1%↓

BBVA

18.59

+0.27%↑

ALV

371.5

+0.05%↑

MUV2

543.6

-0.11%↓

INGA

22.345

-0.62%↓

Search

Gimv NV

Slēgts

SektorsFinanšu

45.3 0.89

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

44.85

Max

45.3

Galvenie mērījumi

By Trading Economics

Pārdošana

114M

P/E

Sektora vidējais

6.165

29.357

EPS

2.43

Darbinieki

94

EBITDA

76M

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.7B

Iepriekšējā atvēršanas cena

44.41

Iepriekšējā slēgšanas cena

45.3

Ziņu noskaņojums

By Acuity

50%

50%

211 / 528 Rangs Finance

Gimv NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 28. nov. 15:29 UTC

Galvenie tirgus virzītāji
Iegādes, apvienošanās, pārņemšana

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

2025. g. 28. nov. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 28. nov. 19:59 UTC

Tirgus saruna

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

2025. g. 28. nov. 19:47 UTC

Tirgus saruna

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

2025. g. 28. nov. 18:16 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 28. nov. 18:16 UTC

Tirgus saruna

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

2025. g. 28. nov. 18:08 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 28. nov. 18:08 UTC

Tirgus saruna

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

2025. g. 28. nov. 17:48 UTC

Tirgus saruna

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

2025. g. 28. nov. 17:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 28. nov. 16:50 UTC

Iegādes, apvienošanās, pārņemšana

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

2025. g. 28. nov. 15:51 UTC

Tirgus saruna

Canada Household Spending Edges Lower -- Market Talk

2025. g. 28. nov. 15:33 UTC

Tirgus saruna

Crude Futures Gain as U.S. Market Reopens -- Market Talk

2025. g. 28. nov. 15:21 UTC

Tirgus saruna

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

2025. g. 28. nov. 15:13 UTC

Tirgus saruna

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

2025. g. 28. nov. 15:11 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 28. nov. 15:11 UTC

Tirgus saruna

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

2025. g. 28. nov. 14:51 UTC

Tirgus saruna

Canada GDP Report Masks Fragile State of Economy -- Market Talk

2025. g. 28. nov. 14:41 UTC

Tirgus saruna

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

2025. g. 28. nov. 14:37 UTC

Tirgus saruna

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

2025. g. 28. nov. 14:33 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 28. nov. 14:33 UTC

Tirgus saruna

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

2025. g. 28. nov. 14:20 UTC

Tirgus saruna

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

2025. g. 28. nov. 14:10 UTC

Tirgus saruna

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

2025. g. 28. nov. 13:39 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 28. nov. 13:39 UTC

Tirgus saruna

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

2025. g. 28. nov. 13:36 UTC

Tirgus saruna

Canada's Economy Expands More Than Expected -- Market Talk

2025. g. 28. nov. 13:29 UTC

Tirgus saruna

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

2025. g. 28. nov. 13:27 UTC

Tirgus saruna

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

2025. g. 28. nov. 13:19 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Gimv NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

211 / 528 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat